1. Home
  2. RLMD vs DAIO Comparison

RLMD vs DAIO Comparison

Compare RLMD & DAIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • DAIO
  • Stock Information
  • Founded
  • RLMD 2004
  • DAIO 1969
  • Country
  • RLMD United States
  • DAIO United States
  • Employees
  • RLMD N/A
  • DAIO N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • DAIO Electrical Products
  • Sector
  • RLMD Health Care
  • DAIO Industrials
  • Exchange
  • RLMD Nasdaq
  • DAIO Nasdaq
  • Market Cap
  • RLMD 20.3M
  • DAIO 22.0M
  • IPO Year
  • RLMD N/A
  • DAIO N/A
  • Fundamental
  • Price
  • RLMD $0.64
  • DAIO $3.36
  • Analyst Decision
  • RLMD Buy
  • DAIO Strong Buy
  • Analyst Count
  • RLMD 3
  • DAIO 2
  • Target Price
  • RLMD $5.00
  • DAIO $4.61
  • AVG Volume (30 Days)
  • RLMD 211.8K
  • DAIO 44.1K
  • Earning Date
  • RLMD 08-11-2025
  • DAIO 07-24-2025
  • Dividend Yield
  • RLMD N/A
  • DAIO N/A
  • EPS Growth
  • RLMD N/A
  • DAIO N/A
  • EPS
  • RLMD N/A
  • DAIO N/A
  • Revenue
  • RLMD N/A
  • DAIO $22,732,000.00
  • Revenue This Year
  • RLMD N/A
  • DAIO $8.59
  • Revenue Next Year
  • RLMD N/A
  • DAIO $6.76
  • P/E Ratio
  • RLMD N/A
  • DAIO N/A
  • Revenue Growth
  • RLMD N/A
  • DAIO N/A
  • 52 Week Low
  • RLMD $0.24
  • DAIO $1.88
  • 52 Week High
  • RLMD $4.02
  • DAIO $3.48
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 50.91
  • DAIO 63.34
  • Support Level
  • RLMD $0.60
  • DAIO $3.10
  • Resistance Level
  • RLMD $0.74
  • DAIO $3.44
  • Average True Range (ATR)
  • RLMD 0.06
  • DAIO 0.11
  • MACD
  • RLMD 0.00
  • DAIO 0.01
  • Stochastic Oscillator
  • RLMD 44.19
  • DAIO 70.00

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

Share on Social Networks: